Epithalon: A Longevity Research Overview
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
Epithalon (also written Epitalon, sequence Ala-Glu-Asp-Gly) is a synthetic tetrapeptide that has become a frequent subject of laboratory aging research. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This overview summarizes what published research has examined regarding Epithalon and telomere biology, the stage that research occupies, and handling considerations relevant to a laboratory setting.
What Epithalon Is
Epithalon is a short four-amino-acid peptide first described by Russian gerontology researchers as a synthetic analogue of a peptide fraction studied in connection with the pineal gland. Because of its small size and defined sequence, it is straightforward to synthesize, which has made it a convenient model compound in laboratory investigations of cellular aging. In research contexts it is handled strictly as a reference material for in vitro and animal-model work, not as a therapeutic agent.
Mechanism and What Research Explores
The central question researchers study with Epithalon is its reported relationship to telomerase, the enzyme that maintains telomeres at the ends of chromosomes. In published research using cultured human somatic cells, investigators reported that adding the peptide was associated with expression of the telomerase catalytic subunit, measurable telomerase enzymatic activity, and elongation of telomeres. Related work examined whether the peptide could interact with promoter regions of genes including telomerase. These are proposed mechanisms studied at the cell and molecular level; researchers continue to examine whether and how such effects are reproducible across different systems.
Research Stage and Limitations
The Epithalon literature is early-stage and predominantly preclinical. Much of the foundational work consists of in vitro cell-culture studies and animal models, with a substantial share originating from a small number of research groups. Independent, large-scale replication remains limited, and the body of controlled human clinical evidence is sparse. As a result, conclusions drawn from these studies should be treated as preliminary and hypothesis-generating rather than established. Community and forum discussions sometimes describe personal impressions; these are unverified anecdotal reports, not controlled findings, and BioRegen does not make or endorse any claims based on them.
Handling and Laboratory Notes
As with many research peptides, Epithalon reference material is typically supplied as a lyophilized powder and is generally stored cold and protected from light and moisture, with reconstitution performed using appropriate solvents in a controlled laboratory environment. For general educational background on preparing lyophilized peptides for in vitro work, see our overview of how to reconstitute peptides. Documentation of lot, purity, and storage conditions supports reproducible research records.
Frequently Asked Questions
Is Epithalon approved for human use?
No. Epithalon is offered and discussed solely as a research compound for laboratory and educational purposes. It is not approved for human or veterinary use, and nothing here should be read as medical advice.
What does the research actually show about telomeres?
In published cell-culture research, the peptide was reported to be associated with telomerase activity and telomere elongation. This is preclinical evidence from specific laboratory systems and has not been established through large-scale controlled human studies.
How does it compare to other studied peptides?
Different research peptides are studied for different proposed mechanisms. To compare reference compounds by research area, you can use our research finder tool.
Selected research references
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003. https://doi.org/10.1023/a:1025493705728
- Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004. https://doi.org/10.1023/b:bebm.0000038164.49947.8c
Reference metadata sourced via PubMed.
Building a research program in cellular aging? Explore our research guide for laboratory background, and use code RESEARCH10 for 10% off your first order. You can also browse related reference materials in our rejuvenation research category.
This article is provided for laboratory and educational research purposes only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. No statement should be interpreted as claiming any compound treats, cures, or prevents any disease. Research compounds are intended solely for qualified in vitro and laboratory research conducted in accordance with all applicable laws and regulations.